AccessPak for HIV PEP Expanded with Viracept and Ranibizumab Intraocular
Determining the interaction of AccessPak for HIV PEP Expanded with Viracept and Ranibizumab Intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / nelfinavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Viracept
Synonyms: n.a.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Viracept-Ranibizumab ophthalmic
- AccessPak for HIV PEP Expanded with Viracept-Ranitidine
- AccessPak for HIV PEP Expanded with Viracept-Ranitidine Capsule
- AccessPak for HIV PEP Expanded with Viracept-Ranitidine Hydrochloride
- AccessPak for HIV PEP Expanded with Viracept-Ranitidine Injection
- AccessPak for HIV PEP Expanded with Viracept-Ranitidine Suspension
- Ranibizumab Intraocular-Accolate
- Ranibizumab Intraocular-Accretropin
- Ranibizumab Intraocular-Accucaine
- Ranibizumab Intraocular-AccuHist Drops
- Ranibizumab Intraocular-AccuHist PDX Drops
- Ranibizumab Intraocular-AccuHist PDX Syrup